GublerDJ, 2002.Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century,Trends Microbiol 10 100 -3
.,Accessed on 8/10/15 -
HalsteadSB, 2007.,Dengue. Lancet 370 1644 -52
RiazMM,MumtazK,KhanMS,PatelJ,TariqM,HilalH, 2009.a clinical perspective,J Pak Med Assoc 59 339 -44
ChaturvediUC,NagarR, 2009.Nitric oxide in dengue and dengue hemorrhagic fever: necessity or nuisance?,FEMS Immunol Med Microbiol 9 -24
SrikiatkhachornA,GreenS., 2010.Markers of dengue disease severity,Curr Top Microbiol Immunol 338 67 -82
MangadaMM,RothmanAL, 2005.Altered cytokine responses of dengue-specific CD4+ T-cells to heterologous serotypes,J immunol 175 2676 -83
TangY,KouZ,ZhangF,YaoX,LiuS, 2010.Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue1 infection among adult Chinese patients,PLoS one 5 1 -8
TsaiTT,ChuangYJ,LinYS,WanSW,ChenCL,LinCF, 2013.An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection,J Biomed Sci 20 40 -
MalavigeGN,FernandoN,OggG, 2011.Pathogenesis of dengue viral infections,Sri Lankan J Infect Dis 1 2 -8
BozzaFA,CruzOG,ZagneS,AzeredoEL,NogueiraR,AssisEF, 2008.Multiple cytokine profile from dengue patients: MIP-l beta and IFN-gamma as predictive factors for severity,BMC Infect Dis 8 86 -
FangX,HuZ,ShangW,ZhuJ,XuC,RaoX, 2012.Genetic polymorphisms of molecules involved in host immune response to dengue virus infection,FEMS Immunol Med Microbiol 66 134 -46
AsadullahK,SterryW,VolkHD, 2003.Interleukin-10 therapy-review of a new approach,Pharm Rev 55 2241 -69
GreenS,RothmanA, 2006.Immunopathological mechanism in dengue and dengue hemorrhagic fever,Curr Opin Infect Dis 19 429 -36
MalavigeGN,FernandoS,FernandoDJ,SeneviratneSL, 2004.Dengue viral infections,Postgrad Med J 80 588 -601
NguyenTH,LeiHY,NguyenTL,LinYS,HuangKJ,LeBL, 2004.Dengue hemorrhagic fever in infants: A study of clinical and cytokine profiles,J Infect Dis 189 221 -32
GurugamaP,GargP,PereraJ,WijewickramaA,SeneviratneSL, 2010.Dengue viral infections,Indian J Dermatol 55 68 -78
UbolS,PhukliaW,KalayanaroojS,ModhiranN, 2010.Mechanism of immune evasion induced by a complex of dengue virus and pre-existing enhancing antibodies,J Infect Dis 201 923 -35
BrasierAR,JuH,GarciaJ,SprattHM,VictorSS,ForsheyBM, 2012.A three-component biomarker panel for prediction of dengue hemorrhagic fever,Am J Med Hyg 86 341 -8
BrooksDG,TrifiloMJ,EdelmannKH,TeytonL,McGavernDB,OldstoneMB, 2006.Interleukin-10 determines viral clearance or persistence in vivo,Nat Med 12 1301 -9
SierraB,PerezAB,VogtK,GarciaG,SchmolkeK,AguirreE, 2010.Secondary heterologous dengue infection risk: disequilibrium between immune regulation and inflammation?,Cell Immunol 262 134 -40
PerezAB,SierraB,GarciaG,AguirreE,BabelN,AlvarezM, 2010.Tumor necrosis factor-alpha, transforming growth factor-β‚ 1 and interleukin-10 gene polymorphism: implication in protection or susceptibility to dengue,Hum Immunol 71 1135 -40